NASDAQ : BOLD
Boundless Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.47 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 56.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 23.24M | 18.71M | 18.00M | 12.16M | 9.31M | 6.02M |
| Research & Development | 43.14M | 44.84M | 55.27M | 42.64M | 37.16M | 19.28M |
| Operating Expenses | 66.38M | 63.55M | 73.27M | 54.80M | 46.47M | 25.30M |
| Operating Income | -66.38M | -63.55M | -73.27M | -54.80M | -46.47M | -25.30M |
| Interest & Investment Income | 4.00M | 5.36M | 7.89M | 5.28M | 668.00K | 96.00K |
| Other Non Operating Income (Expenses) | 1.00K | -2.00K | 12.00K | 80.00K | -100.00K | -5.00K |
| Pretax Income | -64.01M | -58.20M | -65.36M | -49.43M | -45.90M | -25.21M |
| Net Income | -64.01M | -58.20M | -65.36M | -49.43M | -45.90M | -25.21M |
| Net Income to Common | -64.01M | -58.20M | -65.36M | -49.43M | -45.90M | -25.21M |
| Shares Outstanding (Basic) | 22.41M | 22.36M | 16.98M | 1.22M | 1.10M | 860.56K |
| Shares Outstanding (Diluted) | 22.41M | 22.36M | 16.98M | 1.22M | 1.10M | 860.56K |
| EPS (Basic) | -2.86 | -2.60 | -3.85 | -40.65 | -41.81 | -29.29 |
| EPS (Diluted) | -2.86 | -2.60 | -3.85 | -40.65 | -41.81 | -29.29 |
| Free Cash Flow | -56.73M | -47.21M | -63.38M | -47.49M | -40.66M | -25.28M |
| Free Cash Flow Per Share | -2.53 | -2.11 | -3.73 | -39.05 | -37.04 | -29.38 |
| EBITDA | -64.23M | -62.30M | -72.18M | -53.84M | -45.53M | -24.62M |
| D&A For EBITDA | 2.16M | 1.25M | 1.09M | 957.00K | 942.00K | 682.00K |
| EBIT | -66.38M | -63.55M | -73.27M | -54.80M | -46.47M | -25.30M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 20.21M | 17.87M | 26.59M | 23.71M | 10.95M | 34.29M |
| Short-Term Investments | 52.41M | 89.71M | 125.53M | 97.05M | 55.77M | 38.74M |
| Cash & Short-Term Investments | 72.63M | 107.58M | 152.11M | 120.75M | 66.72M | 73.03M |
| Prepaid Expenses | 1.02M | 2.03M | 2.28M | 3.45M | 1.32M | 1.54M |
| Total Current Assets | 73.65M | 109.61M | 154.39M | 124.20M | 68.04M | 74.57M |
| Property, Plant & Equipment | 97.00K | 46.88M | 51.36M | 4.58M | 7.73M | 3.10M |
| Long-Term Investments | 34.99M | |||||
| Other Long-Term Assets | 573.00K | 659.00K | 1.11M | 1.07M | 1.07M | |
| Total Assets | 73.74M | 157.06M | 206.41M | 129.89M | 76.83M | 113.72M |
| Accounts Payable | 1.05M | 1.49M | 1.27M | 2.22M | 1.40M | 1.07M |
| Accrued Expenses | 6.72M | 7.88M | 6.86M | 4.94M | 3.90M | 2.08M |
| Current Portion of Leases | 3.17M | 2.19M | 2.34M | 377.00K | ||
| Other Current Liabilities | 93.00K | 337.00K | ||||
| Total Current Liabilities | 7.77M | 12.54M | 8.13M | 9.36M | 7.73M | 3.87M |
| Long-Term Leases | 45.87M | 47.63M | 2.85M | |||
| Other Long-Term Liabilities | 6.00K | 95.00K | ||||
| Total Liabilities | 7.77M | 58.41M | 55.77M | 9.36M | 10.58M | 3.96M |
| Common Stock | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | |
| Additional Paid-In Capital | 362.92M | 358.26M | 351.99M | 8.99M | 5.38M | 2.76M |
| Retained Earnings | -296.92M | -259.67M | -201.47M | -136.11M | -86.67M | -40.77M |
| Comprehensive Income & Other | -32.00K | 64.00K | 121.00K | 40.00K | -398.00K | -175.00K |
| Total Common Equity | 65.98M | 98.65M | 150.64M | -127.08M | -81.70M | -38.19M |
| Shareholders' Equity | 65.98M | 98.65M | 150.64M | 120.53M | 66.25M | 109.76M |
| Total Liabilities & Equity | 73.74M | 157.06M | 206.41M | 129.89M | 76.83M | 113.72M |
| Total Debt | 49.03M | 47.63M | 2.19M | 5.18M | 377.00K | |
| Net Cash (Debt) | 72.63M | 58.55M | 104.48M | 118.56M | 61.53M | 72.66M |
| Net Cash Per Share | 3.24 | 2.62 | 6.15 | 97.50 | 56.05 | 84.43 |
| Filing Date Shares Outstanding | 22.75M | 22.41M | 22.30M | 1.25M | 1.13M | 860.56K |
| Total Common Shares Outstanding | 22.47M | 22.41M | 22.30M | 1.25M | 1.13M | 860.56K |
| Working Capital | 65.88M | 97.07M | 146.25M | 114.84M | 60.31M | 70.70M |
| Book Value Per Share | 2.94 | 4.40 | 6.76 | -102.02 | -71.99 | -44.38 |
| Tangible Book Value | 65.98M | 98.65M | 150.64M | -127.08M | -81.70M | -38.19M |
| Tangible Book Value Per Share | 2.94 | 4.40 | 6.76 | -102.02 | -71.99 | -44.38 |
| Machinery | 3.54M | 7.12M | 7.05M | 5.25M | 4.69M | 3.70M |
| Leasehold Improvements | 51.00K | 1.05M | 981.00K | 46.00K | 46.00K | 200.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -64.01M | -58.20M | -65.36M | -49.43M | -45.90M | -25.21M |
| Depreciation & Amortization | 2.16M | 1.25M | 1.09M | 957.00K | 942.00K | 682.00K |
| Loss (Gain) From Sale of Investments | -1.58M | -2.59M | -5.05M | -3.30M | 503.00K | 536.00K |
| Stock-Based Compensation | 7.23M | 6.12M | 7.52M | 3.34M | 2.29M | 1.16M |
| Other Operating Activities | 8.68M | 3.29M | 2.65M | 2.38M | 1.70M | 423.00K |
| Change in Accounts Payable | 916.00K | 1.63M | 775.00K | 1.66M | 1.91M | 1.22M |
| Change in Other Net Operating Assets | -11.26M | 1.83M | -2.45M | -2.46M | -1.04M | -2.06M |
| Operating Cash Flow | -56.25M | -46.66M | -60.84M | -46.85M | -39.60M | -23.25M |
| Capital Expenditures | -485.00K | -546.00K | -2.54M | -633.00K | -1.07M | -2.03M |
| Investment in Securities | 61.59M | 38.35M | -23.57M | -37.63M | 17.20M | -57.25M |
| Investing Cash Flow | 61.11M | 37.80M | -26.10M | -38.26M | 16.13M | -59.28M |
| Issuance of Common Stock | 97.00K | 141.00K | 93.17M | 182.00K | 126.00K | 208.00K |
| Other Financing Activities | -3.35M | -1.96M | ||||
| Financing Cash Flow | 97.00K | 141.00K | 89.82M | 97.90M | 126.00K | 105.53M |
| Net Cash Flow | 4.96M | -8.72M | 2.88M | 12.78M | -23.34M | 22.99M |
| Free Cash Flow | -56.73M | -47.21M | -63.38M | -47.49M | -40.66M | -25.28M |
| Free Cash Flow Per Share | -2.53 | -2.11 | -3.73 | -39.05 | -37.04 | -29.38 |
| Levered Free Cash Flow | -30.55M | -31.41M | -37.58M | -30.95M | -24.76M | |
| Unlevered Free Cash Flow | -30.55M | -31.41M | -37.58M | -30.95M | -24.76M | |
| Change in Working Capital | -10.34M | 3.46M | -1.68M | -799.00K | 866.00K | -837.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 56.18M | 26.86M | 64.67M | |||
| Enterprise Value | -16.44M | -40.95M | -102.35M | |||
| Last Close Price | 2.47 | 1.20 | 2.90 | |||
| PB Ratio | 0.84 | 0.27 | 0.43 | |||
| P/TBV Ratio | 0.85 | 0.27 | 0.43 | |||
| Debt / Equity Ratio | 0.50 | 0.32 | 0.02 | 0.08 | 0.00 | |
| Net Debt / Equity Ratio | -1.10 | -0.59 | -0.69 | -0.98 | -0.93 | -0.66 |
| Net Debt / EBITDA Ratio | 1.13 | 0.94 | 1.45 | 2.20 | 1.35 | 2.95 |
| Net Debt / FCF Ratio | 1.28 | 1.24 | 1.65 | 2.50 | 1.51 | 2.87 |
| Quick Ratio | 9.35 | 8.58 | 18.70 | 12.90 | 8.63 | 18.89 |
| Current Ratio | 9.48 | 8.74 | 18.98 | 13.27 | 8.80 | 19.28 |
| Return on Equity (ROE) | -67.86% | -46.69% | -48.21% | -52.93% | -52.16% | |
| Return on Assets (ROA) | -32.77% | -21.86% | -27.23% | -33.13% | -30.48% | |
| Return on Capital Employed (ROCE) | -100.60% | -44.00% | -37.00% | -45.50% | -67.20% | -23.00% |
| Earnings Yield | -115.64% | -216.66% | -101.08% | |||
| FCF Yield | -100.98% | -175.75% | -98.01% | |||
| Buyback Yield / Dilution | -0.37% | -31.65% | -1,296.71% | -10.77% | -27.56% |